- Home
- ORGO vs THRY Comparison
ORGO vs THRY Comparison
Compare ORGO & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- THRY
- Stock Information
- Founded
- ORGO 1985
- THRY 2012
- Country
- ORGO United States
- THRY United States
- Employees
- ORGO N/A
- THRY N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- THRY Industrial Machinery/Components
- Sector
- ORGO Health Care
- THRY Industrials
- Exchange
- ORGO Nasdaq
- THRY Nasdaq
- Market Cap
- ORGO 620.3M
- THRY 580.8M
- IPO Year
- ORGO N/A
- THRY 2020
- Fundamental
- Price
- ORGO $4.90
- THRY $12.47
- Analyst Decision
- ORGO Buy
- THRY Strong Buy
- Analyst Count
- ORGO 2
- THRY 5
- Target Price
- ORGO $7.50
- THRY $21.40
- AVG Volume (30 Days)
- ORGO 761.1K
- THRY 453.5K
- Earning Date
- ORGO 11-11-2025
- THRY 11-06-2025
- Dividend Yield
- ORGO N/A
- THRY N/A
- EPS Growth
- ORGO N/A
- THRY N/A
- EPS
- ORGO N/A
- THRY N/A
- Revenue
- ORGO $429,531,000.00
- THRY $758,289,000.00
- Revenue This Year
- ORGO $2.57
- THRY N/A
- Revenue Next Year
- ORGO $9.80
- THRY N/A
- P/E Ratio
- ORGO N/A
- THRY N/A
- Revenue Growth
- ORGO N/A
- THRY N/A
- 52 Week Low
- ORGO $2.48
- THRY $10.03
- 52 Week High
- ORGO $6.71
- THRY $20.92
- Technical
- Relative Strength Index (RSI)
- ORGO 52.77
- THRY 45.37
- Support Level
- ORGO $4.75
- THRY $12.04
- Resistance Level
- ORGO $5.10
- THRY $13.30
- Average True Range (ATR)
- ORGO 0.21
- THRY 0.52
- MACD
- ORGO -0.02
- THRY -0.05
- Stochastic Oscillator
- ORGO 39.39
- THRY 25.82
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About THRY Thryv Holdings Inc.
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.